The outcomes of GSEA highlighted that the group with over-expression of KLRB1 was mainly concentrated in the cell adhesion (36), and signaling pathways such as B cell receptor, T cell receptor (37), chemokine (38), JAK-STAT, VEGF signaling pathways, and other tumor development-associated pathways. The gene discussed is KLRB1; the disease is neoplasm.